|
Volumn 51, Issue 57, 2015, Pages 11405-11408
|
Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXORUBICIN;
NANOPARTICLE;
POLYPEPTIDE;
ANTINEOPLASTIC ANTIBIOTIC;
DELAYED RELEASE FORMULATION;
ELASTIN;
PEPTIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CARDIOTOXICITY;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG BLOOD LEVEL;
DRUG CONJUGATION;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SYNTHESIS;
DRUG TISSUE LEVEL;
IN VITRO STUDY;
IN VIVO STUDY;
INTERNALIZATION;
MOUSE;
NONHUMAN;
PH;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
TUNEL ASSAY;
ADVERSE EFFECTS;
AMINO ACID SEQUENCE;
ANIMAL;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
HUMAN;
MOLECULAR GENETICS;
NEOPLASMS;
PATHOLOGY;
TUMOR CELL LINE;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
CELL LINE, TUMOR;
DELAYED-ACTION PREPARATIONS;
DOXORUBICIN;
DRUG DELIVERY SYSTEMS;
ELASTIN;
HUMANS;
HYDROGEN-ION CONCENTRATION;
MICE;
MOLECULAR SEQUENCE DATA;
NANOPARTICLES;
NEOPLASMS;
PEPTIDES;
|
EID: 84936971227
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c5cc04035c Document Type: Article |
Times cited : (39)
|
References (23)
|